AK

Anjana Keshavrao Kulkarni

Active Director Director DIN 11211059
DIN 11211059 First appointment Jul 2025 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Anjana Keshavrao Kulkarni

Data last updated:

Anjana Keshavrao Kulkarni is a Director at Sacred Science Pharmaceuticals Private Limited (since 2025). The company operates in Chemicals.

DIN 11211059
Primary Designation Director
Industry Chemicals
First Appointment 24 Jul 2025
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Jul 20252021Active

Directorship timeline

Open interactive timeline →
Sacred Science Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anjana Keshavrao Kulkarni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anjana Keshavrao Kulkarni

Anjana Keshavrao Kulkarni currently holds 1 directorship: Sacred Science Pharmaceuticals Private Limited (Director, since 24 Jul 2025).

Anjana Keshavrao Kulkarni was first appointed on 24 Jul 2025 as Director at Sacred Science Pharmaceuticals Private Limited.

The current boards of Anjana Keshavrao Kulkarni's companies include Hiremath Geeta (Sacred Science Pharmaceuticals Private Limited), Shailaja Raghavendra Kulkarni (Sacred Science Pharmaceuticals Private Limited), Vidya Chandra (Sacred Science Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available